A new study presented at the ENDO 2025 meeting in San Francisco suggests that oxytocin, commonly known as the “love hormone,” could play a protective role in mood disturbances caused by sleep loss and hormonal changes during significant reproductive transitions such as postpartum and menopause.
Researchers from Brigham and Women’s Hospital and Harvard Medical School explored how sleep interruption and estrogen suppression affect mood and oxytocin levels in healthy premenopausal women. The study involved 38 participants who underwent two five-night inpatient protocols: one during their natural hormonal state and another after estradiol suppression. After two nights of normal sleep, their sleep was fragmented for three consecutive nights to mimic the disruptions often experienced during postpartum and menopause. Throughout the study, both mood disturbance and oxytocin levels were carefully measured.
The findings revealed that sleep interruption significantly increased both mood disturbance and oxytocin levels. Notably, women with higher oxytocin levels before experiencing sleep disruption reported less mood disturbance the following day. Additionally, higher levels of mood disturbance after disrupted sleep were associated with increased oxytocin levels the next day, suggesting a possible feedback mechanism.
Dr. Irene Gonsalvez, the study’s lead author, noted,
“We found that oxytocin levels rise in response to stress-related sleep disruption, and that women with higher oxytocin levels before disrupted sleep experienced less mood disturbance the next day. These results point toward oxytocin as a potential biological buffer during periods of hormonal and emotional vulnerability.”
The research highlights the often-overlooked emotional consequences of sleep disturbances during key reproductive transitions and suggests that oxytocin may act as a natural mood modulator. Millions of women face mood symptoms during these periods, yet current treatments typically focus on antidepressants or hormone therapy. Understanding oxytocin’s role could open new avenues for supporting women’s mental health during these vulnerable times.
Disclaimer: This article summarizes findings from a recent scientific study presented at a medical conference. The research is preliminary and has not yet undergone peer review. The information provided should not be interpreted as medical advice or used to guide treatment decisions. Individuals concerned about mood or sleep disturbances should consult a qualified healthcare professional for personalized guidance.